Greenwood Way Capital is a network of funds, family offices and individual investors focusing on early stage British companies with innovative ideas and unique technologies.
Portfolio
3
companies
Micrima
Micrima develops a radio-wave breast scanning system for early cancer detection.
Epipole
Epipole develops portable video retinal imaging technology designed to identify symptoms of preventable blindness.
Sphere Fluidics
Sphere Fluidics creates advanced single cell analysis systems for biotherapeutic discovery.
Ian Leigh
Founder
The funding round was led by Technology Venture Partners alongside government backing to support the commercialisation of a new breast scanning system.
"this investment will allow us to move the company into the next phase with a system that has a place in a clinical workflow and more exciting functionality to come as soon as clinical data collection can re commence"
The funding will prepare the company for its introduction into the United States ophthalmic imaging market.
"We’ve worked with ophthalmologists to test and refine features and capabilities, and will use this funding to implement the key changes needed,"
Greenwood Way Capital and 24Haymarket led the financing round to support international expansion and operations.
"We are delighted to raise this additional funding. Due to our over-subscribed investment round earlier this year, we decided to add on a second tranche to accommodate the additional interest. We are currently recruiting and looking at prospective new facilities in the UK and California to support the growth of our commercial and scientific activities."
